29.03.2010:  Gemcitabine combined with gefitinib in patients with inoperable of metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation

“Gemcitabine combined with gefitinib in patients with inoperable of metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation”
Cancer Invest. 2008 Oct; 26(8):784-93,
Fountzilas G, Bobos M, Kalogera-Fountzila A, Xiros N, Murray S, Linardou H, Karayannopoulou G, Koutras A, Bafaloukos D, Samantas E, Christodoulou C, Economopoulos T, Kalogeras K, Kosmidis P